Who is sponsoring NCT05725980?

NCT05725980 is sponsored by Andrea Scribante.

What drugs are being tested in NCT05725980?

Interventions in NCT05725980: Cephalometric analysis.

What condition does NCT05725980 study?

NCT05725980 studies Skeletal Malocclusion.

Is NCT05725980 still recruiting?

NCT05725980 is currently completed. Last updated 28 March 2023.

Last reviewed 2023-03-28 · How we verify

NCT05725980

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Upper Airways Cephalometric Measures Compared to Skeletal Class and Divergence

Completed Last updated 28 March 2023

What this trial tests

trial testing Cephalometric analysis in Skeletal Malocclusion in 120 participants. Completed in 26 March 2023.

Timeline

12 February 2023

Primary endpoint
20 March 2023

26 March 2023

Quick facts

Lead sponsor	Andrea Scribante
Status	Completed
Study type	OBSERVATIONAL
Enrollment	120
Start date	12 February 2023
Primary completion	20 March 2023
Estimated completion	26 March 2023
Sites	1 location across Italy

Drugs / interventions tested

Cephalometric analysis

Conditions studied

Skeletal Malocclusion — all drugs for Skeletal Malocclusion →

Sponsor

Andrea Scribante

Who can join

Adults 18 to 50, any sex, with Skeletal Malocclusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present study is to investigate the baseline upper airways dimensions in adult patients belonging to all skeletal classes

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Upper Airway Dimensions among Different Skeletal Malocclusions: A Retrospective Observational Study by Cephalometric Analysis.
Sfondrini MF, Gallo S, Pascadopoli M, Gandini P, et al · · 2024 · cited 7× · PMID 38248220 · DOI 10.3390/dj12010012

Verify or expand the search:

Other trials of Cephalometric analysis

Trials testing the same drug.

NCT07360704 — Genotypes and Craniofacial Phenotypes in Orthodontic Patients With Marfan and Loeys-Dietz Syndromes · completed

Other Andrea Scribante trials

Trials by the same sponsor.

NCT07247799 — Ozone Therapy for the Treatment of Oral Mucositis in Patients Undergoing Radio and Chemotherapy in the Head and Neck Reg · completed
NCT07360704 — Genotypes and Craniofacial Phenotypes in Orthodontic Patients With Marfan and Loeys-Dietz Syndromes · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05725980 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Andrea Scribante
Last refreshed: 28 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05725980.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing